Program developed by Medavera, Inc. will take place during IDWeek 2024 LOS ANGELES, Oct. 5, 2024 /PRNewswire/ — With infectious diseases ranking as the third leading cause of death globally and the growing health threat of antimicrobial resistance, multiplex molecular assays are emerging…
